“Siloed procurement is a big problem. We’ve recently worked with a client where a CDMO was selected simply because it could start two weeks before another. Ultimately, that led to about an 18-month delay in the project altogether.” Matthew Holt,
Bora Biologics, a contract development and manufacturing organisation (CDMO) focused on biologics, has signed a partnership with InvaGen Pharmaceuticals Inc., a subsidiary of Cipla Limited, for the production of NYPOZI™. The therapy, a biosimilar to Neupogen®, will be manufactured at
“Outsourcing is about giving the things you don’t excel at to someone who does them exceptionally well. That’s what speeds development and delivery,” says Kindeva’s CEO, Milton Boyer. Milton brings nearly 30 years of pharmaceutical manufacturing experience as a contract
Integrated DNA Technologies (IDT) has announced the launch of its Alt-R™ HDR Enhancer Protein, a new solution designed to improve genome editing outcomes in challenging cell types. The molecule enables up to a two-fold increase in HDR efficiency in cells
Verismo Therapeutics, a clinical-stage CAR T company, has announced the successful manufacture of its first clinical cell product for STAR-101, a Phase 1 trial of its lead candidate SynKIR™-110. The product was manufactured using lentiviral vector supplied by Miltenyi Bioindustry,
Praxis Packaging Solutions has acquired Advanced Concept Innovations, LLC (ACI), a contract packaging provider based in Lakeland, Florida. The move expands Praxis’ geographic footprint into the Southeastern United States and broadens its service offering across multiple market segments. ACI provides
WuXi Biologics has announced the launch of TrueSite TI™, a targeted integration (TI)-based CHO cell line platform designed to streamline biologics development. The new system aims to accelerate development timelines, improve product quality, and ensure stable scalability for antibody and
As the pharmaceutical industry grapples with geopolitical tensions, regulatory shifts, and technological disruption, the question of what constitutes a strong external partnership has never been more critical. We asked industry leaders across CDMOs, biotechs, and technology providers to share their
Merck has announced that Kai Beckmann will take over as Chair of the Executive Board and Chief Executive Officer on 1 May 2026. He will succeed Belén Garijo, who has led the company as CEO since 2021 and will remain
Moderna has officially launched its Innovation and Technology Centre (MITC) at the Harwell Science and Innovation Campus in Oxfordshire, UK. The facility will manufacture British-made mRNA respiratory vaccines to support the National Health Service (NHS) seasonal vaccination programmes. The MITC
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
